Results 31 to 40 of about 12,890,416 (254)

Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia

open access: yesFrontiers in Pharmacology, 2019
Immune-related hematological adverse events are amongst the rare but potentially life-threatening complications of immune checkpoint inhibitors.
Roser Calvo
doaj   +1 more source

Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates   +3 more
core   +1 more source

Details of immune-related adverse events.

open access: yes, 2022
Details of immune-related adverse events.
Yuji Miyoshi (3172629)   +5 more
core   +1 more source

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Christopher J Cates   +3 more
core   +1 more source

Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review

open access: yes, 2022
Immune checkpoint inhibitors have been increasingly used to treat various malignant neoplasms. Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects, referred to as immune-related ...
Elizabeth A. Montgomery   +3 more
core   +1 more source

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer [PDF]

open access: yes, 2022
Editorial on the Research Topic Immune-Related Adverse Events for Patients with Lung ...
Frey, Benjamin   +6 more
core   +1 more source

Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review

open access: yes, 2023
Immune checkpoint inhibitors have been increasingly used to treat various malignant neoplasms. Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects, referred to as immune-related ...
Alruwaii, Zainab I.   +3 more
core   +1 more source

The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors

open access: yesJournal of Experimental & Clinical Cancer Research, 2020
The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle ...
Xiao-Hui Jia   +9 more
doaj   +1 more source

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system

open access: yesThoracic Cancer, 2020
Immunotherapy for malignant tumors is a hot spot in current research and the treatment of cancer. The activation of programmed cell death receptor‐1 (PD‐1) and cytotoxic T lymphocyte‐associated antigen 4 (CTLA)‐4 relevant signaling pathway can inhibit ...
Yue Li   +10 more
doaj   +1 more source

Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study

open access: yesFrontiers in Oncology, 2022
BackgroundImmune checkpoint inhibitors (ICIs) are associated with different immune-related adverse events (irAEs), but there is limited evidence regarding the association between urinary incontinence and ICIs.MethodsWe described the case of a patient ...
Yizhang Hu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy